Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04535648

Detection of Enterovirus Genotypes by CRISPR Technology

Rapid Identification and Clinical Transformation of Various Enterovirus Genotypes Based on CRISPR Technology

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Children's Hospital of Fudan University · Academic / Other
Sex
All
Age
1 Day – 18 Years
Healthy volunteers
Not accepted

Summary

CRISPR-enterovirus detection system was constructed in this study for detection variety genotypes of enterovirus rapidly in children suspected or diagnosed as enterovirus infection.

Detailed description

To construct CRISPR-enterovirus detection system, we screened the targets, primers and CrRNA and evaluated the capability of this detecting system. Samples of feces, blood and cerebrospinal fluid (the remainder of routine testing samples) from 500 children with suspected or confirmed enterovirus infection were examined using the CRISPR technique. To evaluate the CRISPR-enterovirus detection system, real-time PCR and traditional PCR as comparison method was implemented. The method of real-time PCR and traditional PCR were used to detect enterovirus and analyze the genotypes of enterovirus, respectively. According to the results of CRISPR-enterovirus detection system and the comparison method, the positive coincidence rate, negative coincidence rate and consistency of the two methods were calculated. Furthermore, the sensitivity and specificity of the CRISPR-enterovirus detection system for detection of enterovirus were calculated.

Conditions

Interventions

TypeNameDescription
OTHERNon-invasive detection method: CRISPR techonologyThis study was a laboratory diagnostic study without any intervention.

Timeline

Start date
2023-04-01
Primary completion
2024-08-01
Completion
2024-09-01
First posted
2020-09-02
Last updated
2023-06-09

Source: ClinicalTrials.gov record NCT04535648. Inclusion in this directory is not an endorsement.